Navigation Links
Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2009 Goals at JPMorgan Healthcare Conference
Date:1/12/2009

osis pathway, and three randomized chemotherapy combination trials are currently underway to evaluate its potential in the treatment of advanced multiple myeloma, non-small cell lung cancer, and hepatocellular cancer.

In May 2008, HGS initiated dosing in a Phase 1 clinical trial to evaluate the safety and tolerability of its lead IAP inhibitor, HGS1029, as monotherapy in patients with advanced solid tumors. Results of this study will also help identify the recommended dose for Phase 2 trials. The IAP inhibitors are a novel class of compounds that block the activity of IAP (inhibitor of apoptosis) proteins, thus allowing apoptosis to proceed and causing the cancer cells to die. When IAP proteins are over-expressed in cancer cells, they can help cancer cells resist apoptosis and resume growth and proliferation.

FINANCIAL GUIDANCE

During his presentation to the JPMorgan Healthcare Conference, Mr. Watkins will present the following guidance regarding the financial results expected by HGS for the full years 2008 and 2009:

  • HGS expects 2009 net cash burn of less than $25 million, compared with approximately $245 million in 2008.
  • Revenue is expected to increase to $250 million or higher in 2009, from $48 million in 2008.
    • This includes at least $150 million from sale of 20,000 doses of ABthrax.
  • HGS expects cash and investments at year-end 2009 to total approximately $340 million, compared with approximately $365 million at the end of 2008.

PRESENTATION TO BE WEBCAST

Mr. Watkins' presentation to the 27th Annual JPMorgan Healthcare Conference will be webcast and may be accessed at www.hgsi.com. The presentation is scheduled to begin on January 14, 2009 at 7:30 AM Pacific or 10:30 AM Eastern
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Video: New Research Discovers Independent Brain Networks Control Human Walking
2. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
3. Enrollment Begins on Human PK Study for Medidur(TM) FA
4. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
5. Study Confirms Limited Human-To-Human Spread of Avian-Flu Virus in Indonesia in 2006
6. Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process
7. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
8. Dr. Roger Kenneth Hershline PhD MD, CEO of Global Humanceuticals, Inc. Donates New HIV Drug
9. Study Shows Plasma-Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery
10. Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
11. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... SAN DIEGO , May 4, 2015 /PRNewswire/ ... an oncology company focused on the clinical development ... pre-clinical data showing mitochondria-specific effects of the Company,s ... significantly enhanced anti-tumor activity when combined with a ... study found ME-344 to be a potent inhibitor ...
(Date:5/4/2015)... 4, 2015 The Pharmacy Workforce Center recently ... that pharmacy has shifted toward a female-dominated profession. With ... managers, there is an incredible opportunity for women to ... decade. In a new blog post ... Insights , Eden Sulzer, director of the Women ...
(Date:5/4/2015)... -- NeuroSigma ® , Inc. (NeuroSigma), a California ... study of its Thin Film Nitinol (TFN) flow diverter were ... at the 53 rd Annual Meeting of the American ... A copy of the study abstract can be accessed via ... Mayo Clinic was primarily funded through a Small Business Technology ...
Breaking Medicine Technology:MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies 2MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies 3MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies 4MEI Pharma's Mitochondrial Inhibitor ME-344 Shows Enhanced Anti-Tumor Activity in Combination with Tyrosine-Kinase Inhibitor in Pre-Clinical Studies 5Cardinal Health Expert Discusses Latest Research On Gender Gap In Pharmacy 2Cardinal Health Expert Discusses Latest Research On Gender Gap In Pharmacy 3NeuroSigma's Thin Film Nitinol Flow Diverting Stent Results Presented at the American Society of Neuroradiology Meeting 2NeuroSigma's Thin Film Nitinol Flow Diverting Stent Results Presented at the American Society of Neuroradiology Meeting 3NeuroSigma's Thin Film Nitinol Flow Diverting Stent Results Presented at the American Society of Neuroradiology Meeting 4
(Date:5/4/2015)... San Diego Fertility Center (SDFC) ... brand new, 13,700 square foot facility scheduled to open ... not only provide fertility treatment and services for the ... and educational events to a number of local and ... door to their current Carmel Valley/Del Mar location and ...
(Date:5/4/2015)... May 04, 2015 Dr. Benjamin Stong ... proudly offers the latest non-surgical double-chin eliminator. Dr. ... plastic surgeon in Atlanta to offer Kybella treatments ... be injected specifically under the chin, promising to safely ... Before Kybella, patients who sought immediate solutions for their ...
(Date:5/4/2015)... May 04, 2015 Unlike some camps, the Nike ... knowledge. The goal is to educate first and train second, ... This ensures that the young runners are building the knowledge base ... few of the topics covered include Effort Based Training, Running Heroes, ... used to be? This is not a camp where kids ...
(Date:5/4/2015)... Dr. Richard Champagne, DMD, MAGD is pleased to ... America’s Best Dentist Award, given by the National Consumer ... dentist is a reflection of his vast experience in ... for his patients. , Each year, the National Consumer ... field. These nominees are dentists who have exceptionally high ...
(Date:5/4/2015)... (PRWEB) May 04, 2015 Sylvia Hawthorn-Deppen shared ... hopes that it would remind others in similar situations that ... Recovery from Chronic Pain and Discovery of New Energy” (published ... a new audience via a renewed press campaign. , “I ... debilitating pain ,” Hawthorn-Deppen says. “As an adolescent I ...
Breaking Medicine News(10 mins):Health News:San Diego Fertility Center Hosted a Ribbon Cutting Ceremony at Its New, Expanded Facility 2Health News:San Diego Fertility Center Hosted a Ribbon Cutting Ceremony at Its New, Expanded Facility 3Health News:Facial Plastic Surgeon First in Atlanta To Offer Kybella Treatments To Reduce Chin Fat 2Health News:US Sports Camps and Select Nike Running Camps Offer Programs for Middle School Runners 2Health News:New Jersey Dentist Dr. Richard Champagne Nominated for America’s Best Dentist Award 2Health News:Author launches new press campaign for 2012 book ‘Wheel’ 2
... Teens Still Feel Targeted By Tobacco Advertising and Find ... Kids across Delaware,will rally against tobacco on April 2 ... 13th annual Kick Butts Day, sponsored by the,Campaign for ... (for a list of local events, go to ...
... By Tobacco Advertising and Find It,Easy to Buy Cigarettes, ... against tobacco on April 2 as they join thousands ... Day, sponsored by the,Campaign for Tobacco-Free Kids. Hundreds of ... local events, go to, http://www.kickbuttsday.org/events )., This year, ...
... (OTC,Bulletin Board: BNLB) is pleased to announce that sales ... at the beginning of this year, have,exceeded the company,s ... 2008., Fusion,s 6+ Hour Energy Shot was first ... past November, where it was voted,"Best Tasting Shot". Fusion ...
... N.C., March 27 Marshall Erdman &,Associates ... company by,"Modern Healthcare,s" 2008 Construction & Design ... the healthcare industry; it,examines year-over-year sales, contracted ... in business and number of architects, engineers,and ...
... 27 Biotest Pharmaceuticals,Corporation, a leading developer ... announcement that a Hepatitis B Immune Globulin,Intravenous ... received,Orphan Drug designation by the U.S. Food ... hepatitis B recurrence following orthotopic liver,transplantation., ...
... major licensing deals like the one his company recently ... front of mind for rising Australian biotechnology star, Antisense ... when he meets with leading industry figures in the ... scientists chosen from a highly competitive field of candidates ...
Cached Medicine News:Health News:Delaware Kids 'Kick Butts' on April 2 2Health News:Delaware Kids 'Kick Butts' on April 2 3Health News:Georgia Kids 'Kick Butts' on April 2 2Health News:Georgia Kids 'Kick Butts' on April 2 3Health News:Bond Laboratories' First Quarter Fiscal 2008 Sales Exceeding Internal Projections 2Health News:'Modern Healthcare' Names Marshall Erdman Nation's Top Design-Build Company 2Health News:Biotest Pharmaceuticals Corporation Responds to Orphan Drug Act Announcement 2Health News:Antisense therapeutics scientist out to pull more big deals 2
Freedom of movement - plus full circle, maximum radiation protection. No other full circle radiation protection design approaches the level of comfort of the VestSkirt, which divides weight between t...
... Cryo System is the first in portability and performance. ... surgeons who need a flexible, portable system with the ... CTU attaches easily to an "E" size tank and ... cryo to where it is needed.,The CTU Travel Case ...
... an easy-to-use, workflow-based system designed to save you ... of the SleepWorks software and either the Connex ... systems can be used for a complete range ... full EEG recording - and have superior signal ...
... Merci Retrieval System is made up of ... Merci Microcatheter and the Merci Balloon Guide ... Once the location of the clot has ... Guide Catheter is inserted through a small ...
Medicine Products: